Financials
- Market Capitalization 11.34 B
- Employee 3 000
- Founded 1976
- CEO Charles R. Kummeth
- Website www.bio-techne.com
- Headquarter Minnesota, United States
- FIGI BBG000C15114
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
60.91
売上高対価格比率
9.13
1株当たり配当金
0.32
配当利回り(%)
0.45
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 821 | CORT Corcept Therapeutics Incorporated - Common Stock | 110.43 USD | -2.60% | -7.40% | -2.27% | +50.51% | 11.94 B USD | ||
| 836 | SMMT Summit Therapeutics Inc. - Common Stock | 14.60 USD | +3.11% | +1.96% | +10.61% | -26.49% | 11.65 B USD | ||
| 855 | AXSM Axsome Therapeutics, Inc. - Common Stock | 209.92 USD | +3.50% | +2.40% | -1.37% | +61.23% | 11.00 B USD | ||
| 857 | KRYS Krystal Biotech, Inc. - Common Stock | 369.23 USD | +1.48% | +3.25% | +17.32% | +97.31% | 10.93 B USD |